Table 1.
Basic demographic, epidemiological and clinical data on patients.
| Age group (years) | Number of patients N (%) |
Male N (%) |
Risk factors | Patients for whom vaccination is indicated* | Case fatality rate N (%) |
|||
|---|---|---|---|---|---|---|---|---|
| Without risk factors |
One or more risk factors |
Two or more risk factors |
PCV 13 | PPSV23 | ||||
| 18–49 | 80 (20.6) | 53 (66.3) | 25 (31.3) | 55 (68.8) | 26 (32.5) | 18 (22.5) | 38 (47.5) | 9 (11.3) |
| 50–64 | 124 (31.9) | 70 (56.5) | 33 (26.6) | 91 (73.4) | 26 (21.0) | 37 (29.8) | 77 (62.1) | 12 (9.7) |
| 65–74 | 94 (24.2) | 49 (52.1) | 0 | 94 (100) | 72 (76.6) | 34 (36.2) | 66 (70.2) | 11 (11.7) |
| ≥ 75 | 91 (23.4) | 42 (46.2) | 0 | 91 (100) | 77 (84.6) | 25 (27.5) | 68 (74.7) | 32 (35.2) |
| Total | 389 (100) | 214 (55.0) | 58 (14.9) | 331 (85.1) | 229 (58.9) | 114 (29.3) | 249 (64.0) | 64 (16.5) |
*They differ according to the type of vaccine and the current recommendations of the Croatian Institute of Public Health.
PCV13–13-valent pneumococcal conjugate vaccine; PPSV – 23-valent pneumococcal polysaccharide vaccine.